TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: pain intensity during prolonged sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rates for delivering the full dose of 2 mL viscous solution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ease of use and acceptance results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: injection-related anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: proportion of laboratory-confirmed COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Epiphyseal rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: refractive prediction error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle activation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical outcomes of the affected knees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: xerostomic burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean 12-month tacrolimus CV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion achieving low tacrolimus CV (tacrolimus CV < 40%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PMA-stimulated ROS production one-hour post-exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: overall reflective thinking
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NF-κB expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ABS-NA
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: IES-I
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 1-hour postprandial glucose (PPG) daily mean
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: premeal to 1-hour postmeal PPG excursion daily mean
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAQ‐DI ≥0.35 improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: medical care visit frequency
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Correction of crossbites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in maxillary intermolar region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in intercanine distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Survival Time (SPT)
Endpoint domain: Mortality/survival
Primary endpoint: Success rate of the first attempt at endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative glottic injury and hoarseness
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and tolerability of TAK-071
Endpoint domain: Adverse events/effects
Primary endpoint: Mean half-life of TAK-071
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative EEG analysis results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Long-term oxygen therapy or death
Endpoint domain: Mortality/survival
Primary endpoint: Prevention of shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Value of curriculum for communication skills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incorporation of feedback into future patient encounters
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Interest in future HVC curricula
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Percentage of spermatozoa with intact acrosome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of reactive oxygen species-positive spermatozoa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active pain levels measured by VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days to extended leg elevation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Slope of eGFR decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Adjusted mean difference in NT-proBNP from placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: any drug use (excluding alcohol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Maximum Inspiratory Pressure (MIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity (PA) at 6-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in plasma insulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area under the curve of 3-MH concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intratesticular testosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Concordance for IHC ERBB2 score 0 vs 1+
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphine equivalents used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiomyocyte proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in examination scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cholesterol level and colon cancer risk
Endpoint domain: Mortality/survival
Primary endpoint: Thermal asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postpreparation contamination rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Return to Work (RTW) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean HEI-2015 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NSFS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Freedom from ATa recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Peripheral glycaemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean GA growth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Xanthine oxidase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean annual cost savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Comfort scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective vision quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of FM symptomatology
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Increase of butyric acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Variation of gut bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in common carotid arteries intima-media thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Systemic drug exposure (area under the curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of epinephrine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean wound size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: complex attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: collagen density of the skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: moisture of the skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: elasticity of the skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean score of WHO ordinal scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean days for the total duration of the symptomatic phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about CMV
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Engagement in activities that may increase the risk of CMV transmission
Endpoint domain: Life impact
Endpoint subdomain: Behavioral change
Primary endpoint: Quality of Life (QOL) as measured by FLIE total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: global brain atrophy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Japanese Orthopaedic Association hip scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corneal nerve fiber density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: anaerobic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total EOM volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total orbital fat volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EOM inflammation reduction based on MRI signal intensity ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eating patterns improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: earlier discharge from hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: rate of psychotropic polypharmacy
Endpoint domain: Adverse events/effects
Primary endpoint: chance of having a fall during hospital stay
Endpoint domain: Adverse events/effects
Primary endpoint: Radiographic osteoarthritis progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of second ACL injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: lung cancer-specific survival (LCSS)
Endpoint domain: Mortality/survival
Primary endpoint: resolution of hyperinflammatory state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: regression of lung lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: discharge from hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: agoraphobic avoidance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥50% reduction in HAM-D score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in inflammatory biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient awareness of regulatory review process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with access to new medicines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Desire for involvement in reimbursement and approval processes
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Percentage of sealed enamel demineralization (%SHL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First postoperative exhaust time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of active bowel sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: modified Rankin Scale scores 0‐2 at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total ingested liquid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tolerability of purgative
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in the use of potentially inappropriate medications
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in medication costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Knowledge of food allergies
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: FA self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Practice behavior in FA management
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: maternal quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: FOXP3 Treg level change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of sepsis severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance and gait improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach the energy goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Correlation of LA and DHA using NMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful outcomes at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in shoulder external rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in mental health discussion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: detection of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: referral to social worker or psychiatrist
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Peak moment of the quadriceps muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cardiovascular Disease (CVD) association
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in Prostate Volume (PV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment receipt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment enactment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: epidermal thinning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: VAS rest score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak levels and perioperative changes in blood lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of vasoplegia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean arterial pressure (MAP) values during CPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 5-year absolute cardiovascular risk scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pain at ADLs score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSCE 2 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: burden of care
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: pain remembered after seven postoperative days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WBDLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher knee strength of the affected side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically relevant change-scores in favour of RT on HOOS-Sport/Rec
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to ascend and descend stairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's average weekly physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of MACEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion achieving ≥5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive performance for BAP1 mutation status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: processing time per image
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: freedom from ATR
Endpoint domain: Mortality/survival
Primary endpoint: Response selection/inhibition improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rapid visual information processing improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median sleep efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: wake after sleep onset (WASO)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: total sleep time (TST)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in depth of bone erosion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Identification of hemolytic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of major infection
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic sensitivity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Responsibility for student motivation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Growth mindset beliefs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fixed mindset beliefs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Children's behavior during dental treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain perception during restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length or realism of patients' LE self-estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median costs per QALY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median OKS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: sustained viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: better lipid profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MOAA/S
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic efficacy for LNM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained pulmonary aspiration
Endpoint domain: Adverse events/effects
Primary endpoint: Pneumothorax
Endpoint domain: Adverse events/effects
Primary endpoint: 180-day primary composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body weight component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nutritional status (MUST risk)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Competitive employment at 5-year follow-up
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Rate of post-operative atrial fibrillation (POAF) after discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Citations in the Web of Science core collection
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: insulin daily doses reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TB care capacity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total body weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total serum cholesterol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Shear bond strength at the composite resin‐dentin interface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MODQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: walking function retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QTc prolongation or other ECG changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: COVID test positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: time spent within the predefined SpO2 range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent with hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes